BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $7,000 | -12.5% | 7,000 | -12.5% | 0.00% | – |
Q2 2022 | $8,000 | -20.0% | 8,000 | -20.0% | 0.00% | – |
Q1 2022 | $10,000 | -16.7% | 10,000 | -9.1% | 0.00% | – |
Q4 2021 | $12,000 | +9.1% | 11,000 | 0.0% | 0.00% | – |
Q3 2021 | $11,000 | 0.0% | 11,000 | 0.0% | 0.00% | – |
Q2 2021 | $11,000 | -47.6% | 11,000 | -47.6% | 0.00% | – |
Q1 2021 | $21,000 | +5.0% | 21,000 | +10.5% | 0.00% | – |
Q4 2020 | $20,000 | +33.3% | 19,000 | +35.7% | 0.00% | – |
Q3 2020 | $15,000 | +25.0% | 14,000 | +40.0% | 0.00% | – |
Q2 2020 | $12,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
KBC Group NV | 400,000 | $40,316,000 | 0.15% |
PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |